FDA Approves Elucirem (gadopiclenol) for Contrast-Enhanced Magnetic Resonance Imaging (MRI)

FDA approval of Elucirem™ (NDA 216986) was granted after priority review, a designation assigned to applications for drugs that provide significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news